Dr Sandra Schulz

Dr Sandra Schulz
Dr Sandra Schulz
Biotechnologist
CeMOS
Delegate / Speaker

Presentations at Label-free Mass Spectrometry Assays for Early Drug Discovery

Profile of Dr Sandra Schulz

I graduated from the University of Applied Sciences Bremen (Germany) with a B.Sc. in Technical and Applied Biology in 2008. From 2007 till 2009, I worked in the company Laboratorios Cryopharma in Mexico in the department of pharmaceutical development developing galenic formulations and analytical methods for solid oral dosage forms. Afterwards, I continued with a Master degree in Biotechnology (focus Biomedical Science and Technology) at Mannheim University of Applied Sciences (Germany), and completed my thesis at Cellzome, a GSK company, in Heidelberg (Germany) in the department of Assay Development. In 2016, I obtained my Ph.D. degree from Heidelberg University (Germany) in Carsten Hopf´s research group in the field of mass spectrometry imaging in drug discovery focussing on distribution studies of small molecule compounds in human and animal tissue. I later moved on to the field of MALDI TOF mass spectrometry cell assays in the Hopf lab (CeMOS) working as a team leader for the development of drug screening assays. I am currently a project manager of the research consortium M2Aind in Mannheim (Germany) and active in teaching in practical lab courses at Mannheim University of Applied Sciences.

Colleagues

Dr Manasi Gaikwad
PostDoc
CeMOS
Prof Carsten Hopf
Head of CeMOS
CeMOS

Email

Please login to send a Private Message

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'